Bank of New York Mellon Corp - MOLECULIN BIOTECH INC ownership

MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 24 filers reported holding MOLECULIN BIOTECH INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of MOLECULIN BIOTECH INC
ValueSharesWeighting
Q4 2019$65,000
-16.7%
70,6780.0%0.00%
Q3 2019$78,000
+90.2%
70,678
+113.8%
0.00%
Q2 2019$41,000
+51.9%
33,0520.0%0.00%
Q1 2019$27,000
-25.0%
33,052
-3.7%
0.00%
Q4 2018$36,00034,3060.00%
Other shareholders
MOLECULIN BIOTECH INC shareholders Q2 2019
NameSharesValueWeighting ↓
Whitegate Investment Counselors, Inc. 101,781$93,0000.02%
Renaissance Technologies 1,007,364$922,0000.00%
Patriot Financial Group Insurance Agency, LLC 2,500$2,0000.00%
Prestige Wealth Management Group LLC 1,000$1,0000.00%
UBS Group AG 19,817$18,0000.00%
ROYAL BANK OF CANADA 2,073$2,0000.00%
COMMONWEALTH EQUITY SERVICES, LLC 12,000$10,0000.00%
DIMENSIONAL FUND ADVISORS LP 17,194$16,0000.00%
WELLS FARGO & COMPANY/MN 3,132$3,0000.00%
NORTHERN TRUST CORP 66,305$61,0000.00%
View complete list of MOLECULIN BIOTECH INC shareholders